Circulating vascular endothelial growth factor (VEGF) is not a prognostic indicator in malignant melanoma

Cancer Letters

Volumn 125, Issue 1-2, 1998, Pages 35-38

  Viac, J ^a   Schmitt, D ^a   Claudy, A ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

ELISA; Malignant melanoma; Metastasis; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; MALE; MELANOMA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032513089     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00499-0     Document Type: Article

References (28)

1. Altomonte M., Colizzi F., Esposito G., Maio M. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N. Engl. J. Med. 327:1992;959.
2. 121. Cancer Res. 55:1995;5296-5301.
3. Ballaun C., Weninger W., Uthman A., Weich H., Tschachler E. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J. Invest. Dermatol. 104:1995;7-10.
4. Barnhill R., Frandrey K., Levy M., Mihm M.J., Hyman B. Angiogenesis and tumor progression of melanoma: quantification of vascularity in melanocytic nevi and cutaneous melanoma. Lab. Invest. 67:1992;331-337.
5. Berse B., Brown L.F., Van de Water L., Dvorak H., Senger D.R. Vascular permeability (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell. 3:1992;211-220.
6. Brossart P., Keilholz U., Willhauck M.et al. Hematogenous spread of malignant melanoma cells in different stages of disease. J. Invest. Dermatol. 101:1993;887-889.
7. Busam K.L., Berwick M., Blessing K.et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am. J. Pathol. 147:1995;1049-1056.
8. Claffey K.P., Brown L.F., del Aguila L.F.et al. Expression of vascular dermeability factor/vascular endothelial growth factor in melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56:1996;172-181.
9. Deijn M., Ruiter D. The possible role of angiogenesis in the metastatic potential of human melanoma. Clinico-pathological aspects. Melanoma Res. 3:1993;5-14.
10. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev. 13:1992;18-32.
11. Freeman M.R., Schneck F.X., Gagnon M.L.et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55:1995;4140-4145.
12. Gabrilovitch D.I., Chen H.L., Girgis K.R.et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 10:1996;1096-1103.
13. Graham C., Rivers J., Kerbel R., Stankiewicz K., White W. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanoma. Am. J. Pathol. 145:1994;510-514.
14. Johnson J.P., Stade B.G., Holzmann B.et al. De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc. Natl. Acad. Sci. USA. 86:1989;641-644.
15. Kondo S., Asano M., Matsuo K., Ohmori I., Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta. 1221:1994;211-214.
16. Liu B., Earl H.M., Baban D.et al. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem. Biophys. Res. Commun. 217:1995;721-727.
17. Macchiarini P., Fontanini G., Hardin M., Squatini F., Angletti C. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet. 340:1992;145-146.
18. Melnyk O., Shuman M.A., Kim K.J. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res. 56:1996;921-924.
19. Mustonen T., Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell. Biol. 129:1995;895-898.
20. Natali P., Nicotra M.R., Cavaliere R.et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res. 50:1990;1271-1278.
21. Senger D.R., Peruzzi C.A., Feder J., Dvorak H.F. A highly conserved vascular permeability factor secreted by a variety of human and rodent cell lines. Cancer Res. 46:1986;5629-5632.
22. Sunderkötter C., Steinbring K., Goebeler M., Bhardwaj R., Sorg C. Macrophages and angiogenesis. J. Leuk. Biol. 55:1994;410-414.
23. Viac J., Guéniche A., Faure M., Claudy A. Soluble intercellular adhesion molecule 1 and malignant melanoma. Cancer Lett. 72:1993;191-194.
24. Viac J., Misery L., Schmitt D., Claudy A. Follow-up of circulating ICAM-1 in malignant melanoma: correlation with the clinical course of the disease. Br. J. Dermatol. 134:1996;604-605.
25. Viac J., Vincent C., Palacio S., Schmitt D., Claudy A. Tumor necrosis factor (TNF) soluble receptors in malignant melanoma: correlation with soluble ICAM-1 levels. Eur. J. Cancer. 3:1996;447-449.
26. Weidner N., Carroll P., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143:1993;401-409.
27. Weidner N., Semple J., Welch W., Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8.
28. Yeo K.T., Wang H.H., Nagy J.A.et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res. 53:1993;2912-2918.